EPIZYME, INC. Active Patents
2 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2022-08-18: Application 17904570; Invention SETD2 INHIBITORS AND RELATED METHODS AND USES, INCLUDING COMBINATION THERAPIES; Applicant EPIZYME, INC.; Status Patented Case.
- 2022-03-08: Application 17689704; Invention METHODS OF TREATING CANCER; Applicant Epizyme, Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-18 | 17904570 | SETD2 INHIBITORS AND RELATED METHODS AND USES, INCLUDING COMBINATION THERAPIES | EPIZYME, INC. | Patented Case | 2026-07-28 | 12691111 | US20230133671A1 | Maria Alejandra RAIMONDI Jennifer Anne TOTMAN Vinny MOTWANI Katherine Louise COSMOPOULOS John LAMPE | United States United States United States United States United States | JOHNSON, CHRISTOPHER LINDSAY |
| 2022-03-08 | 17689704 | METHODS OF TREATING CANCER | Epizyme, Inc. | Patented Case | 2024-12-10 | 12162865 | US20220315566A1 | Sarah K. KNUTSON Natalie WARHOLIC Heike KEILHACK | United States United States United States | HOWELL, THEODORE R |